Skip to content

Evaluation of Hair Removal Efficacy of the Bai Tian E Qiang Mai Pulsed Light Hair Removal Device and the Auxiliary Effect of Light-conducting Gel: A Randomized, Self-controlled Study

Evaluation of Hair Removal Efficacy of the Bai Tian E Qiang Mai Pulsed Light Hair Removal Device and the Auxiliary Effect of Light-conducting Gel: A Randomized, Self-controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119887
Enrollment
Unknown
Registered
2026-03-05
Start date
2026-03-07
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Control group:Use of the Bai Tian E Intense Pulsed Light (IPL) Hair Removal Device
Experimental group:Use of the Bai Tian E Intense Pulsed Light (IPL) Hair Removal Device combined with light-conducting gel

Sponsors

Dematology Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18–60 years, Asian (Chinese), healthy females; 2.Self-perceived sensitive skin; 3.Self-perceived excessive axillary hair and with hair removal demands; 4.History of using home-use hair removal devices; 5.Able to understand the trial procedures, voluntarily participate in the trial and sign a written informed consent form;

Exclusion criteria

Exclusion criteria: 1.Those who have applied any topical medications to the test sites within the past two months; 2.Those who have taken antihistamines within the past week or immunosuppressants within the past month; 3.Those with unresolved inflammatory dermatoses; 4.Patients with insulin-dependent diabetes mellitus; 5.Patients with asthma or other chronic respiratory diseases currently under treatment; 6.Those who have received anticancer chemotherapy within the past six months; 7.Patients with immunodeficiency or autoimmune diseases; 8.Women who are planning pregnancy, pregnant or lactating; 9.Those with obvious scars, pigmentation, atrophy, port-wine stains, sunburn, wounds, abrasions, tattoos or other skin defects on or near the skin test sites that may interfere with the evaluation of trial results; 10.Those who have received photorejuvenation, laser therapy or other facial cosmetic procedures that may affect skin condition within the past three months; 11.Those who have participated in similar facial trials, oral drug trials or other clinical trials within the past two months; 12.Subjects with highly sensitive constitutions, or known to be allergic to ingredients in cosmetics, daily chemicals, alcohol, rubber or medications; 13.Those who need to be chronically exposed to outdoor sunlight due to work or other reasons; 14.Those with other iatrogenic conditions that may affect the trial results (e.g., history of coagulation disorders, severe hyperglycemia, hypertension, hyperlipidemia, mental illness or other major diseases); 15.Those deemed unsuitable for trial participation by clinical assessment; 16.Those who are non-voluntary participants or unable to complete the required trial procedures as instructed;

Design outcomes

Primary

MeasureTime frame
Hair count;

Secondary

MeasureTime frame
Skin a* value;Hair density;Stratum corneum moisture content;NRS score;Skin ITA° value;Skin firmness;Transepidermal water loss;Skin elasticity;

Countries

China

Contacts

Public ContactYe Li

Dematology Hospital of Southern Medical University

dlpfbyy@163.com+86 20 83028375

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026